Effect of ticagrelor combined with nicorandil on endothelial function and coronary blood flow after PCI treatment in STEMI patients

被引:0
|
作者
Li, Guiru [1 ]
Yue, Dongmei [1 ]
机构
[1] Shanghai Univ Med & Hlth Sci, Affiliated Chongming Hosp, Dept Cardiol, Shanghai 202150, Peoples R China
关键词
STEMI; PCI; Ticagrelor; Nicorandil;
D O I
10.22514/sv.2024.147
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
This study investigated the effect of ticagrelor combined with nicorandil on endothelial function and coronary blood flow after percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). We retrospectively analyzed 300 STEMI patients who underwent emergency PCI, 150 in the observation group and 150 in the control group. The control group was given oral ticagrelor. The observation group received oral nicorandil along with the control group. A significant improvement in peak ejection rate (PER) and left ventricular (LV) ejection fraction (EF) occurred after the operation, while LV end-diastolic volume index (LVESVI), LV end-diastolic internal diameter (LVEDD), cardiac troponin I (cTnI), and creatine kinase myoglobin (CK-MB) were significantly reduced compared to the preoperative period. Improvements in cardiac function were significantly greater in the observation group than in the control group (p < 0.05). After the operation, both groups' serum nitric oxide (NO) and endothelin-1 (ET-1) levels were greatly higher and lower, respectively, during the preoperative period (p <0.05). The observation group's serum NO level was significantly higher than the control group's, and its ET-1 level was substantially lower than the control group's (p < 0.05). There was a significant increase in thrombolysis in myocardial infarction (TIMI) flow grade 3 percentage and TIMI myocardial perfusion grade (TMPG) grade 3 percentage in the observation group in the immediate postoperative period compared to the control group, despite a significantly lower corrected TIMI Frame count (CTFC) (p < 0.05). 1 month postoperatively, major adverse cardiovascular events (MACE) incidence was significantly lower in the observation group than in the control group (chi(2) = 3.914, p = 0.048). The preoperative combination of ticagrelor and nicorandil in STEMI patients undergoing PCI helped attenuate vascular endothelial function impairment, improved coronary blood flow, and promoted postoperative cardiac function recovery.
引用
收藏
页码:75 / 81
页数:7
相关论文
共 50 条
  • [41] Recovery of regional myocardial function after CTO PCI compared to no CTO PCI in STEMI patients with a concurrent CTO
    Elias, Joelle
    van Dongen, Ivo
    Hoebers, Loes
    Ouweneel, Dagmar
    Claessen, Bimmer
    Henriques, Jose
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B61 - B61
  • [42] Analysis of the effect of platelet function and different doses of ticagrelor after flow diverter treatment of intracranial aneurysms
    Ge, Runze
    Lin, Jiancheng
    Feng, Xin
    Huang, Chi
    Huang, Jiwan
    Li, Can
    Wen, Zhuohua
    Xu, Anqi
    Huang, Mengshi
    Yuan, Hao
    Shi, Hongyu
    Ma, Gengwu
    Yi, Ruizhe
    Liang, Shuyin
    Bi, Yiming
    Su, Shixing
    Zhang, Xin
    Li, Xifeng
    Duan, Chuanzhi
    NEUROSURGICAL REVIEW, 2025, 48 (01)
  • [43] PRE PRIMARY PERCUTANEOUS CORONARY INTERVENTION TIMI FLOW GRADES IN STEMI PATIENTS PRE-LOADED WITH TICAGRELOR
    Jan, Z.
    Ullah, I.
    Ibrahim, M.
    Kiernan, T.
    HEART, 2018, 104 : A32 - A32
  • [44] Changes of coronary blood flow before and after post-dilation following primary percutaneous coronary intervention in patients with STEMI
    Xu, Meng-Cheng
    Zhao, Maolin
    MEDICINE, 2024, 103 (46)
  • [45] Onset of antiplatelet effect of prasugrel and ticagrelor is delayed in STEMI/NSTEMI patients undergoing percutaneous coronary intervention
    Trenk, D.
    Leggewie, S.
    Stratz, C.
    Nuehrenberg, T.
    Ferenc, M.
    Schmitz, R.
    Valina, C. M.
    Hochholzer, W.
    Neumann, F. -J
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S84 - S84
  • [46] Vascular endothelial function in patients with slow coronary flow
    Sezgin, AT
    Sigirci, A
    Barutcu, I
    Topal, E
    Sezgin, N
    Ozdemir, R
    Yetkin, E
    Tandogan, I
    Kosar, F
    Ermis, N
    Yologlu, S
    Bariskaner, E
    Cehreli, S
    CORONARY ARTERY DISEASE, 2003, 14 (02) : 155 - 161
  • [47] Effect of ticagrelor combined with metoprolol extended-release tablets on cardiac function and clinical prognosis in elderly patients with acute coronary syndrome after percutaneous coronary intervention
    Wang, Lili
    Gao, Linlin
    Chen, Qin
    Chen, Li
    Xu, Hui
    Sun, Ling
    Hu, Youbin
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2025, 12
  • [48] Effect of pre-hospital treatment for STEMI patients undergoing primary PCI
    Fabris, Enrico
    Menzio, Sara
    Gregorio, Caterina
    Pezzato, Andrea
    Stolfo, Davide
    Aleksova, Aneta
    Vitrella, Giancarlo
    Rakar, Serena
    Perkan, Andrea
    Van't Hof, Arnoud W. J.
    Sinagra, Gianfranco
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [49] Effect of pre-hospital treatment for STEMI patients undergoing primary PCI
    Fabris, Enrico
    Menzio, Sara
    Gregorio, Caterina
    Pezzato, Andrea
    Stolfo, Davide
    Aleksova, Aneta
    Vitrella, Giancarlo
    Rakar, Serena
    Perkan, Andrea
    Van't Hof, Arnoud W. J.
    Sinagra, Gianfranco
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [50] Absence of differential effect of ticagrelor versus prasugrel maintenance dose on endothelial function in patients with stable coronary artery disease
    Xanthopoulou, Ioanna
    Bei, Ilianna
    Bampouri, Theodora
    Barampoutis, Nikolaos
    Moulias, Athanasios
    Davlouros, Periklis
    Alexopoulos, Dimitrios
    HELLENIC JOURNAL OF CARDIOLOGY, 2019, 59 (06) : 338 - 343